Evidence map›Paper›PMID 32747607›Full record

ArticleRNA (New York, N.Y.)2020

Impact of virus subtype and host

Peter Simmonds, Lize Cuypers, Will L Irving, John McLauchlan, Graham S Cooke, Ellie Barnes, STOP-HCV Consortium, M Azim Ansari

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Covid-19 and the need for more history and philosophy of RNA.History and philosophy of the life sciences · 2021
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Peter SimmondsNuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, OX1 3SY, Oxford, United Kingdom.ORCID 0000-0002-7964-4700
Lize CuypersUniversity of Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Clinical and Epidemiological Research, BE 3000, Leuven, Belgium.
Will L IrvingFaculty of Medicine and Health Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, NG7 2UH, United Kingdom.
John McLauchlanMRC-University of Glasgow Centre for Virus Research, Glasgow, G61 1QH, United Kingdom.
Graham S CookeImperial College London, London, W2 1PG, United Kingdom.
Ellie BarnesNuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, OX1 3SY, Oxford, United Kingdom.
STOP-HCV Consortium
M Azim AnsariNuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, OX1 3SY, Oxford, United Kingdom.ORCID 0000-0003-2790-8353
University of Oxford · GBMRC University of Glasgow Centre for Virus Research · GBNottingham University Hospitals NHS Trust · GBRega Institute for Medical Research · BEThe London College · GB

Funding

Department of Health 14/02/17Medical Research Council MC_UU_12014/1Medical Research Council MR/K010239/1Medical Research Council MR/K01532X/1Medical Research Council MR/P025064/1MRF_ C0365Wellcome Trust 200838/Z/16/ZWellcome Trust WT103767MA
6 · The paper itself

Abstract

Mechanisms underlying the ability of hepatitis C virus (HCV) to establish persistent infections and induce progressive liver disease remain poorly understood. HCV is one of several positive-stranded RNA viruses capable of establishing persistence in their immunocompetent vertebrate hosts, an attribute previously associated with formation of large-scale RNA structure in their genomic RNA. We developed novel methods to analyze and visualize genome-scale ordered RNA structure (GORS) predicted from the increasingly large data sets of complete genome sequences of HCV. Structurally conserved RNA secondary structure in coding regions of HCV localized exclusively to polyprotein ends (core, NS5B). Coding regions elsewhere were also intensely structured based on elevated minimum folding energy difference (MFED) values, but the actual stem-loop elements involved in genome folding were structurally poorly conserved, even between subtypes 1a and 1b. Dynamic remodeling was further evident from comparison of HCV strains in different host genetic backgrounds. Significantly higher MFED values, greater suppression of UpA dinucleotide frequencies, and restricted diversification were found in subjects with the TT genotype of the rs12979860 SNP in the

Indexed as

Polymorphism, Single NucleotideGenome, ViralGenotypeHepacivirusHepatitis CHumansInterferon LambdaInterleukinsModels, MolecularNucleic Acid ConformationPhylogenyRNA, ViralIFNL4 protein, humanInterferon LambdaInterleukinsRNA, ViralevolutionHCVinterferon lambdaRNA secondary structureRNaseLUpA dinucleotide

Identifiers

PMID32747607
PMCPMC7566573
OpenAlexW3047504310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.